AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
TOXICITY AND EFFICACY OF DEFINED DOSES OF CD4(-MARROW TRANSPLANT() DONOR LYMPHOCYTES FOR TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE)
Authors: ALYEA EP SOIFFER RJ CANNING C NEUBERG D SCHLOSSMAN R PICKETT C COLLINS H WANG YL ANDERSON KC RITZ J
Citation: Ep. Alyea et al., TOXICITY AND EFFICACY OF DEFINED DOSES OF CD4(-MARROW TRANSPLANT() DONOR LYMPHOCYTES FOR TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE), Blood, 91(10), 1998, pp. 3671-3680
HIGH-DOSE CHEMORADIOTHERAPY AND ANTI-B-CELL MONOCLONAL-ANTIBODY PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MANTLE-CELL LYMPHOMA - NO EVIDENCE FOR LONG-TERM REMISSION
Authors: FREEDMAN AS NEUBERG D GRIBBEN JG MAUCH P SOIFFER RJ FISHER DC ANDERSON KC ANDERSEN N SCHLOSSMAN R KROON M RITZ J ASTER J NADLER LM
Citation: As. Freedman et al., HIGH-DOSE CHEMORADIOTHERAPY AND ANTI-B-CELL MONOCLONAL-ANTIBODY PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MANTLE-CELL LYMPHOMA - NO EVIDENCE FOR LONG-TERM REMISSION, Journal of clinical oncology, 16(1), 1998, pp. 13-18
CD6(-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA() T)
Authors: SOIFFER RJ FREEDMAN AS NEUBERG D FISHER DC ALYEA EP GRIBBEN J SCHLOSSMAN RL BARTLETTPANDITE L KUHLMAN C MURRAY C FREEMAN A MAUCH P ANDERSON KC NADLER LM RITZ J
Citation: Rj. Soiffer et al., CD6(-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA() T), Bone marrow transplantation, 21(12), 1998, pp. 1177-1181
EFFICACY AND COSTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN ALLOGENEIC T-CELL DEPLETED BONE-MARROW TRANSPLANTATION
Authors: LEE SJ WELLER E ALYEA EP RITZ J SOIFFER RJ SOIFFER J
Citation: Sj. Lee et al., EFFICACY AND COSTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN ALLOGENEIC T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, Blood, 92(8), 1998, pp. 2725-2729
ADMINISTRATION OF R24 MONOCLONAL-ANTIBODY AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
Authors: SOIFFER RJ CHAPMAN PB MURRAY C WILLIAMS L UNGER P COLLINS H HOUGHTON AN RITZ J
Citation: Rj. Soiffer et al., ADMINISTRATION OF R24 MONOCLONAL-ANTIBODY AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA, Clinical cancer research, 3(1), 1997, pp. 17-24
DONOR LYMPHOCYTE INFUSIONS - THE DOOR IS OPEN
Authors: SOIFFER RJ
Citation: Rj. Soiffer, DONOR LYMPHOCYTE INFUSIONS - THE DOOR IS OPEN, Journal of clinical oncology, 15(2), 1997, pp. 416-417
GUILLAIN-BARRE-SYNDROME FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: WEN PY ALYEA EP SIMON D HERBST RS SOIFFER RJ ANTIN JH
Citation: Py. Wen et al., GUILLAIN-BARRE-SYNDROME FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Neurology, 49(6), 1997, pp. 1711-1714
CHARACTERIZATION OF T-CELL REPERTOIRE IN PATIENTS WITH GRAFT-VERSUS-LEUKEMIA AFTER DONOR LYMPHOCYTE INFUSION
Authors: CLARET EJ ALYEA EP ORSINI E PICKETT CC COLLINS H WANG YL NEUBERG D SOIFFER RJ RITZ J
Citation: Ej. Claret et al., CHARACTERIZATION OF T-CELL REPERTOIRE IN PATIENTS WITH GRAFT-VERSUS-LEUKEMIA AFTER DONOR LYMPHOCYTE INFUSION, The Journal of clinical investigation, 100(4), 1997, pp. 855-866
SIMILAR DISEASE-FREE SURVIVAL (DFS) AFTER ALLOGRAFTING AND AUTOGRAFTING FOR MULTIPLE-MYELOMA (MM)
Authors: SCHLOSSMAN RL WEBB I ALYEA EP SOIFFER RJ FISHER D VANCE E GRIBBEN J FREEDMAN A NADLER L RITZ J ANDERSON KC
Citation: Rl. Schlossman et al., SIMILAR DISEASE-FREE SURVIVAL (DFS) AFTER ALLOGRAFTING AND AUTOGRAFTING FOR MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 994-994
OUTCOME FOLLOWING T-CELL DEPLETED (TCD) VERSUS NON-T-CELL DEPLETED (NON-TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPACT OF DONOR LYMPHOCYTE INFUSIONS (DLI)
Authors: SEHN LH ANTIN JH WELLER E ALYEA EP CANNING C RITZ J SOIFFER RJ
Citation: Lh. Sehn et al., OUTCOME FOLLOWING T-CELL DEPLETED (TCD) VERSUS NON-T-CELL DEPLETED (NON-TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPACT OF DONOR LYMPHOCYTE INFUSIONS (DLI), Blood, 90(10), 1997, pp. 1006-1006
DOSE-ESCALATION OF TOTAL-BODY IRRADIATION (TBI) IN RECIPIENTS OF CD6 DEPLETED ALLOGENEIC BONE-MARROW - TOXICITY AND ANTITUMOR EFFECTS
Authors: SOIFFER RJ MAUCH P NEUBERG D ALYEA E FISHER D SCHLOSSMAN R GRIBBEN J VANCE E FREEDMAN A ANDERSON K KUHLMAN C MARCUS K NADLER L RITZ J
Citation: Rj. Soiffer et al., DOSE-ESCALATION OF TOTAL-BODY IRRADIATION (TBI) IN RECIPIENTS OF CD6 DEPLETED ALLOGENEIC BONE-MARROW - TOXICITY AND ANTITUMOR EFFECTS, Blood, 90(10), 1997, pp. 1011-1011
TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION
Authors: RICHARDSON PG ELIAS AD KRISHNAN A WHEELER C NATH R HOPPENSTEADT D WALLER EK ANTIN JH SOIFFER RJ VREDENBURGH J BEARMAN SI IACOBELLI M FAREED J GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 90(10), 1997, pp. 1107-1107
GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF) AFTER T-CELL DEPICTED (TCD) ALLOGENEIC TRANSPLANTATION (ALLOBMT) - EFFICACY AND COSTS
Authors: LEE SJ WELLER E ALYEA EP RITZ J SOIFFER RJ
Citation: Sj. Lee et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF) AFTER T-CELL DEPICTED (TCD) ALLOGENEIC TRANSPLANTATION (ALLOBMT) - EFFICACY AND COSTS, Blood, 90(10), 1997, pp. 1659-1659
PROLONGED TIME TO CYTOGENETIC AND MOLECULAR RESPONSE IN PATIENTS WITHRELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER DONOR LYMPHOCYTE INFUSION (DLI)
Authors: ALYEA EP CANNING C SOIFFER RJ RITZ J
Citation: Ep. Alyea et al., PROLONGED TIME TO CYTOGENETIC AND MOLECULAR RESPONSE IN PATIENTS WITHRELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER DONOR LYMPHOCYTE INFUSION (DLI), Blood, 90(10), 1997, pp. 2442-2442
EXPANSION OF PREEXISTING CLONAL POPULATIONS FOLLOWING DONOR LYMPHOCYTE INFUSION FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ORSINI E ALYEA EP SCHLOSSMAN R SOIFFER RJ ANDERSON KC RITZ J
Citation: E. Orsini et al., EXPANSION OF PREEXISTING CLONAL POPULATIONS FOLLOWING DONOR LYMPHOCYTE INFUSION FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 2446-2446
ALLOGENEIC GRAFT-VERSUS-LEUKEMIA IS DIRECTED AGAINST HOST HEMATOPOIETIC ANTIGENS AND IS NOT LEUKEMIA SPECIFIC AS DETERMINED BY CYTOGENETIC AND MOLECULAR ANALYSIS IN PATIENTS WITH CML FOLLOWING DONOR LYMPHOCYTEINFUSION
Authors: ALYEA EP CHILLEMI A CANNING C SOIFFER RJ RITZ J
Citation: Ep. Alyea et al., ALLOGENEIC GRAFT-VERSUS-LEUKEMIA IS DIRECTED AGAINST HOST HEMATOPOIETIC ANTIGENS AND IS NOT LEUKEMIA SPECIFIC AS DETERMINED BY CYTOGENETIC AND MOLECULAR ANALYSIS IN PATIENTS WITH CML FOLLOWING DONOR LYMPHOCYTEINFUSION, Blood, 90(10), 1997, pp. 2620-2620
ALTERED TYROSINE PHOSPHORYLATION VIA THE VERY LATE ANTIGEN (VLA) BETA-1 INTEGRIN STIMULATION IS ASSOCIATED WITH IMPAIRED T-CELL SIGNALING THROUGH VLA-4 AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION/
Authors: SATO T OHASHI Y TACHIBANA K SOIFFER RJ RITZ J MORIMOTO C
Citation: T. Sato et al., ALTERED TYROSINE PHOSPHORYLATION VIA THE VERY LATE ANTIGEN (VLA) BETA-1 INTEGRIN STIMULATION IS ASSOCIATED WITH IMPAIRED T-CELL SIGNALING THROUGH VLA-4 AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION/, Blood, 90(10), 1997, pp. 4222-4229
CD6-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: SOIFFER RJ FAIRCLOUGH D ROBERTSON M ALYEA E ANDERSON K FREEDMAN A BARTLETTPANDITE L FISHER D SCHLOSSMAN RL STONE R MURRAY C FREEMAN A MARCUS K MAUCH P NADLER L RITZ J
Citation: Rj. Soiffer et al., CD6-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN FIRST COMPLETE REMISSION, Blood, 89(8), 1997, pp. 3039-3047
EXPANSION AND MANIPULATION OF NATURAL-KILLER-CELLS IN PATIENTS WITH METASTATIC CANCER BY LOW-DOSE CONTINUOUS-INFUSION AND INTERMITTENT BOLUS ADMINISTRATION OF INTERLEUKIN-2
Authors: SOIFFER RJ MURRAY C SHAPIRO C COLLINS H CHARTIER S LAZO S RITZ J
Citation: Rj. Soiffer et al., EXPANSION AND MANIPULATION OF NATURAL-KILLER-CELLS IN PATIENTS WITH METASTATIC CANCER BY LOW-DOSE CONTINUOUS-INFUSION AND INTERMITTENT BOLUS ADMINISTRATION OF INTERLEUKIN-2, Clinical cancer research, 2(3), 1996, pp. 493-499
IMMUNOTHERAPY OF RESPIRATORY SYNCYTIAL VIRUS PNEUMONIA FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: DEVINCENZO JP LEOMBRUNO D SOIFFER RJ SIBER GR
Citation: Jp. Devincenzo et al., IMMUNOTHERAPY OF RESPIRATORY SYNCYTIAL VIRUS PNEUMONIA FOLLOWING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 17(6), 1996, pp. 1051-1056
PREVENTION OF TRANSMISSION OF HEPATITIS-G VIRUS IN BONE-MARROW TRANSPLANTATION BY TREATING THE DONOR WITH ALPHA-INTERFERON
Authors: VANCE EA SOIFFER RJ MCDONALD GB MYERSON D FINGEROTH J RITZ J
Citation: Ea. Vance et al., PREVENTION OF TRANSMISSION OF HEPATITIS-G VIRUS IN BONE-MARROW TRANSPLANTATION BY TREATING THE DONOR WITH ALPHA-INTERFERON, Transplantation, 62(9), 1996, pp. 1358-1360
R24 ANTI-GD3 GANGLIOSIDE ANTIBODY CAN INDUCE CO-STIMULATION AND PREVENT THE INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL CLONAL ANERGY
Authors: BOUSSIOTIS VA PARDO NA COLLINS H HOUGHTON A RITZ J NADLER LM SOIFFER RJ
Citation: Va. Boussiotis et al., R24 ANTI-GD3 GANGLIOSIDE ANTIBODY CAN INDUCE CO-STIMULATION AND PREVENT THE INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL CLONAL ANERGY, European Journal of Immunology, 26(9), 1996, pp. 2149-2154
HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING FIRST REMISSION
Authors: FREEDMAN AS GRIBBEN JG NEUBERG D MAUCH P SOIFFER RJ ANDERSON KC PANDITE L ROBERTSON MJ KROON M RITZ J NADLER LM
Citation: As. Freedman et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING FIRST REMISSION, Blood, 88(7), 1996, pp. 2780-2786
DEFECTIVE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: PIGNATA C SANGHERA JS SOIFFER RJ CHARTIER S EDER M PELECH SL RITZ J
Citation: C. Pignata et al., DEFECTIVE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(6), 1996, pp. 2334-2341
DISTINCT CHANGES IN T-CELL REPERTOIRE ASSOCIATED WITH GVL AND GVHD INPATIENTS RECEIVING DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ORSINI E CLARET EJ ALYEA EP SCHLOSSMAN R CANNING C SOIFFER RJ ANDERSON KC RITZ J
Citation: E. Orsini et al., DISTINCT CHANGES IN T-CELL REPERTOIRE ASSOCIATED WITH GVL AND GVHD INPATIENTS RECEIVING DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1020-1020
Risultati: 1-25 | 26-49